Default company panoramic image
Logo

Novocor Medical Systems

Novocor develops products that enable paramedics to treat cardiac arrest victim in the field by rapidly inducing hypothermia.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Raleigh, NC, USA
  • Currency USD
  • Founded March 2013
  • Employees 5
  • Website novocormed.com

Company Summary

Every year 420K americans go into cardiac arrest and over 90% will die or suffer permanent brain damage. Clinical studies has shown the survival rate can be increased by 50% with rapid induction of therapeutic hypothermia (TH). Novocor develops products that enable paramedics to rapidly induce TH at the earliest possible moment, simultaneously with resuscitation efforts. The product will be sold directly to EMS agencies for use on ambulances.

Team

  • Default avatar
    Andrew DiMeo
    VP of Alliances and Founder

    Andrew is Assistant Professor of the Practice and Director of Industrial Relations at the UNC/NCSU Joint Dept of Biomedical Engineering. Andrew was founder of the North Carolina Medical Device Organziation, which served as the foundation for ibiliti. He was co-founder of Gilero Biomedical. Andrew received his Ph.D. from the UNC/NCSU Joint Department of Biomedical Engineering, MS from UNC's Medical School, and BS in Physics from UNC Charlotte.

  • Ef6d1692 1413 494d b1f3 5167b8ac7c36
    CEO and Founder

    Tony has over 20 years of experience in medical device and pharmaceutical development. Prior to Novocor, Tony spent most of his career at Closure Medical (acquired by Ethicon in 2005) as Director of R&D and Site leader, where he was responsible for approximately 80 associates. Tony has 10 issued US patents and has developed over a dozen commercial class II (510k) and class III (PMA) medical devices, including Dermabond® Topical Skin Adhesive.

  • 79f58d81 9694 4806 9fc8 9950e47c6c92
    VP of R&D and Founder

    Javier is a biomedical engineer with more than 9 years of medical device innovation experience at Smith & Nephew and Bioventus, LLC. Javier earned his Ph.D. in biomedical engineering at the University of Michigan on a Fulbright scholarship. During this time he was involved in the early stages of a university spinout, Xoran Technologies. Javier has been involved in product development projects from the initial idea to launch.

  • Default avatar
    Bob Wood
    VP of Sales and Marketing

    Bob brings over 30 years of sales, marketing and senior sales management experience to Novocor with sales roles at Medrad (now a Bayer company), Cordis, Perclose, and Novoste as VP of WW Sales and Marketing. In 2005, he joined Acclarent to start up the commercial operations serving as VP U.S. Sales. After JNJ’s acquisition of Acclarent, Bob spent 2 years serving as Chief Commercial Officer for OrbusNeich.

  • Default avatar
    Kevin Leite
    VP of Operations

    Kevin has 18 years of experience leading Operations groups in medical device and pharmaceuticals, most recently as Business Unit Manager for Ethicon. Prior to Ethicon, Kevin joined Closure Medical Corporation (acquired by Ethicon) and held positions of Director of Engineering and Director of Operations. His responsibilities during this time included transitioning new products (Class II and Class III) into manufacturing and overall Operations.

Advisors

  • Default avatar
    Merrill Mason
    Lawyer
    Unconfirmed
    Default avatar
    Bill Starling
    Board Member
    Unconfirmed
    Default avatar
    Richard Staub
    Board Member
    Unconfirmed
  • 7aad0d2d f278 4dee b4e0 9a110dc2ce82
    Board Member
    86d56962 ec7b 4ba8 b090 f2b570b104f5
    Board Member